Thus, a significant reduction in ductal proliferation in CDE-fed mice lacking Fn14 activity represents therapeutically promising data for potentially targeting this pathway in chronic pancreatitis to inhibit the progression to cancer. This evidence concerns the gene TNFRSF12A and chronic pancreatitis.